Investor Relations Waleed Hassanein – President and Chief Executive Officer Stephen Gordon – Chief Financial Officer Conference Call Participants Allen Gong – JPMorgan William Plovanic – Canaccord ...

Investing.com -- TD Cowen downgraded SolarEdge Technologies (NASDAQ:SEDG) from Buy to Hold in a research note, citing ongoing challenges in European markets that are expected to delay the company ...

TD Cowen analyst Josh Jennings maintained a Buy rating on Boston Scientific (BSX – Research Report) today and set a price target of $100.00. The company’s shares closed yesterday at $83.99.

TD Cowen analyst Josh Jennings maintained a Buy rating on Humacyte (HUMA – Research Report) today and set a price target of $10.00. The company’s shares closed yesterday at $4.86. Jennings ...

TD Cowen has maintained a Hold rating on Moderna shares (NASDAQ: NASDAQ:MRNA), with a consistent price target of $60.00. The firm's update came ahead of the biotech sector's third-quarter earnings ...

TD Cowen has shown a modest increase in confidence in Lyft Inc. (NASDAQ: NASDAQ:LYFT), adjusting the price target slightly upward to $16 from the previous $15 while maintaining a Hold rating on ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Investing.com -- TD Cowen downgraded SolarEdge Technologies (NASDAQ:SEDG) from Buy to Hold in a research note, citing ongoing challenges in European markets that are expected to delay the company’s ...

SolarEdge Technologies (NASDAQ:SEDG) -4.2% in Monday's trading after TD Cowen downgraded shares to Hold from Buy with a $16 price target, slashed from $35, citing deteriorating demand in Europe ...

Fintel reports that on October 29, 2024, TD Cowen downgraded their outlook for Tapestry (LSE:0LD5) from Buy to Hold. As of October 22, 2024, the average one-year price target for Tapestry is 49.50 ...

On Monday, TD Cowen maintained a Hold rating on VF Corp (NYSE:VFC), with a consistent price target of $16.00. The stance comes amid investor and analyst uncertainty regarding the company's sales and ...